Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.
- DOI
- 10.1016/j.jacadv.2025.102459
- Published
- 2026 Jan
- Container
- JACC. Advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacadv.2025.102459,
title = {Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.},
author = {Tavares CAM and Azevedo LCP and Guimarães PO and Rea-Neto Á and David-João PG and Campos NS and Amendola CP and Kozesinski-Nakatani AC and Filiponi TC and Almeida GMB and Bergo RR and Lobo SM and Tognon AP and Tavares MS and Silveira FS and Dracoulakis MDA and Biondi RS and Monfardini F and Nieri J and Madrini V Jr and Serpa-Neto A and Bacal F and Lemos PA and Berwanger O and Ezekowitz JA and Zampieri FG and DEFENDER Investigators},
year = {2026},
journal = {JACC. Advances},
doi = {10.1016/j.jacadv.2025.102459},
url = {https://doi.org/10.1016/j.jacadv.2025.102459}
}RIS
TY - JOUR TI - Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial. AU - Tavares CAM AU - Azevedo LCP AU - Guimarães PO AU - Rea-Neto Á AU - David-João PG AU - Campos NS AU - Amendola CP AU - Kozesinski-Nakatani AC AU - Filiponi TC AU - Almeida GMB AU - Bergo RR AU - Lobo SM AU - Tognon AP AU - Tavares MS AU - Silveira FS AU - Dracoulakis MDA AU - Biondi RS AU - Monfardini F AU - Nieri J AU - Madrini V Jr AU - Serpa-Neto A AU - Bacal F AU - Lemos PA AU - Berwanger O AU - Ezekowitz JA AU - Zampieri FG AU - DEFENDER Investigators PY - 2026 JO - JACC. Advances DO - 10.1016/j.jacadv.2025.102459 UR - https://doi.org/10.1016/j.jacadv.2025.102459 ER -
APA
CAM, T., LCP, A., PO, G., Á, R., PG, D., NS, C., CP, A., AC, K., TC, F., GMB, A., RR, B., SM, L., AP, T., MS, T., FS, S., MDA, D., RS, B., F, M., J, N., Jr, M. V., A, S., F, B., PA, L., O, B., JA, E., FG, Z., & Investigators, D. (2026). Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.. JACC. Advances. https://doi.org/10.1016/j.jacadv.2025.102459
Source records
- pubmed · retrieved 2026-09-26T12:24:38.283Z
- europe-pmc · retrieved 2026-09-26T12:24:38.276Z